These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


395 related items for PubMed ID: 12004654

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Salivary enhancement: current status and future therapies.
    Atkinson JC, Baum BJ.
    J Dent Educ; 2001 Oct; 65(10):1096-101. PubMed ID: 11699983
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New approaches to preventing xerostomia.
    J Support Oncol; 2006 Feb; 4(2):87-8. PubMed ID: 16499130
    [No Abstract] [Full Text] [Related]

  • 6. The use of oral pilocarpine in xerostomia and Sjögren's syndrome.
    Nusair S, Rubinow A.
    Semin Arthritis Rheum; 1999 Jun; 28(6):360-7. PubMed ID: 10406404
    [Abstract] [Full Text] [Related]

  • 7. Pilocarpine treatment in a mixed cohort of xerostomic patients.
    Aframian DJ, Helcer M, Livni D, Robinson SD, Markitziu A, Nadler C.
    Oral Dis; 2007 Jan; 13(1):88-92. PubMed ID: 17241436
    [Abstract] [Full Text] [Related]

  • 8. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
    Komai K, Shiozawa K, Tanaka Y, Yoshihara R, Tanaka C, Sakai H, Yamane T, Murata M, Tsumiyama K, Hashiramoto A, Shiozawa S.
    Mod Rheumatol; 2009 Jan; 19(4):416-9. PubMed ID: 19452244
    [Abstract] [Full Text] [Related]

  • 9. The therapy of Sjogren's syndrome: a review.
    Coaccioli S, Giuliani M, Puxeddu A.
    Clin Ter; 2007 Jan; 158(5):453-6. PubMed ID: 18062353
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P.
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [Abstract] [Full Text] [Related]

  • 11. Assessing salivary gland hypofunction--Part two.
    Muzyka BC.
    Pract Proced Aesthet Dent; 2002 Apr; 14(3):262. PubMed ID: 12004635
    [No Abstract] [Full Text] [Related]

  • 12. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations.
    von Bültzingslöwen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, Wray D, Brennan MT, Carrozzo M, Gandera B, Fujibayashi T, Navazesh M, Rhodus NL, Schiødt M.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S57.e1-15. PubMed ID: 17379156
    [Abstract] [Full Text] [Related]

  • 13. Unraveling the mysteries of saliva: its importance in maintaining oral health. Transcript of a lecture presented on August 6 at the 2006 AGD Annual Meeting & Exposition.
    Crossley H.
    Gen Dent; 2007 Mar; 55(4):288-96. PubMed ID: 17682636
    [No Abstract] [Full Text] [Related]

  • 14. Management of salivary hypofunction during and after radiotherapy.
    Shiboski CH, Hodgson TA, Ship JA, Schiødt M.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S66.e1-19. PubMed ID: 17379158
    [Abstract] [Full Text] [Related]

  • 15. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.
    Arisawa H, Imai E, Fujise N, Fukui K, Masunaga H.
    Arzneimittelforschung; 2002 Mar; 52(1):14-20. PubMed ID: 11838269
    [Abstract] [Full Text] [Related]

  • 16. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
    Nieuw Amerongen AV, Veerman EC.
    Support Care Cancer; 2003 Apr; 11(4):226-31. PubMed ID: 12673460
    [Abstract] [Full Text] [Related]

  • 17. Salivary hypofunction and xerostomia: diagnosis and treatment.
    Atkinson JC, Grisius M, Massey W.
    Dent Clin North Am; 2005 Apr; 49(2):309-26. PubMed ID: 15755407
    [Abstract] [Full Text] [Related]

  • 18. [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
    Ogawa N, Shimoyama K, Karasawa H, Fukushima T, Masaki Y, Wano Y, Hirose Y, Sugai S.
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):330-7. PubMed ID: 15559322
    [Abstract] [Full Text] [Related]

  • 19. An update on the management for the dental patient with Sjögren's syndrome and xerostomia.
    Rhodus NL.
    Northwest Dent; 1999 Oct; 78(4):27-34. PubMed ID: 11819900
    [Abstract] [Full Text] [Related]

  • 20. Parotid irrigation and cevimeline gargle for treatment of xerostomia in Sjögren's syndrome.
    Takagi Y, Katayama I, Tashiro S, Nakamura T.
    J Rheumatol; 2008 Nov; 35(11):2289-91. PubMed ID: 19004065
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.